Faculty, Staff and Student Publications
Publication Date
12-1-2022
Journal
Current Osteoporosis Report
Abstract
Purpose of review: In this review, we discuss the mechanism of action of gabapentinoids and the potential consequences of long-term treatment with these drugs on the musculoskeletal system.
Recent findings: Gabapentinoids, such as gabapentin (GBP) and pregabalin (PGB) were designed as antiepileptic reagents and are now commonly used as first-line treatment for neuropathic pain and increasingly prescribed off-label for other pain disorders such as migraines and back pain. GBP and PGB exert their analgesic actions by selectively binding the α2δ1 auxiliary subunit of voltage-sensitive calcium channels, thereby inhibiting channel function. Numerous tissues express the α2δ1 subunit where GBP and PGB can alter calcium-mediated signaling events. In tissues such as bone, muscle, and cartilage, α2δ1 has important roles in skeletal formation, mechanosensation, and normal tissue function/repair that may be affected by chronic use of gabapentinoids. Long-term use of gabapentinoids is associated with detrimental musculoskeletal outcomes, including increased fracture risk. Therefore, understanding potential complications is essential for clinicians to guide appropriate treatments.
Keywords
Humans, Calcium, Gabapentin, gamma-Aminobutyric Acid, Homeostasis, Pregabalin, Gabapentin, Pregabalin, α2δ1, Bone, Muscle, Cartilage
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Musculoskeletal Diseases Commons, Oncology Commons, Orthopedics Commons
Comments
PMID: 36149592